Azenta Life Sciences Announces Fiscal 2022 Second Quarter Earnings Conference Call and Webcast
Azenta, Inc. (Nasdaq: AZTA) will announce its fiscal 2022 second quarter earnings on May 3, 2022, after market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Azenta, Inc. (Nasdaq: AZTA) will announce its fiscal 2022 second quarter earnings on May 3, 2022, after market close. The results will cover the quarter ending March 31, 2022. A conference call to discuss these results is scheduled for 4:30 p.m. Eastern Time on the same day, accessible via phone and live webcast. Azenta specializes in life sciences solutions, offering cold-chain sample management and genomic services to major pharmaceutical and biotech companies worldwide.
Positive
- Scheduled announcement of earnings may reflect financial growth.
- Potential for positive investor engagement through the conference call.
Negative
- None.
Details
News Market Reaction – AZTA
The recorded move for AZTA in the trading session of this news was -0.14%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CHELMSFORD, Mass., April 14, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal 2022 second quarter earnings which ended on March 31, 2022 on Tuesday, May 3, 2022 after the market closes.
The Company will host a conference call and live webcast to discuss its financial results on the same day, Tuesday, May 3, 2022 at 4:30 p.m. Eastern Time. To participate in the conference call, please dial 800-926-6194 for domestic callers and +1-212-231-2922 for international callers.
Analysts, investors and members of the media can access the live webcast via the Azenta website at https://investors.azenta.com/events. A replay will be available beginning at 8:30 a.m. ET on May 4, 2022.
About Azenta Life Sciences
Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. As of December 1st, the company changed its name and ticker to Azenta, Inc. (Nasdaq: AZTA) from Brooks Automation, Inc, (Nasdaq: BRKS).
Azenta is headquartered in Chelmsford, MA, with operations in North America, Europe and Asia. For more information, please visit www.azenta.com.
INVESTOR CONTACTS:
Sara Silverman
Director, Investor Relations
Azenta Life Sciences
978.262.2635
sara.silverman@azenta.com
Sherry Dinsmore
Azenta Life Sciences
978.262.2400
sherry.dinsmore@azenta.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/azenta-life-sciences-announces-fiscal-2022-second-quarter-earnings-conference-call-and-webcast-301526211.html
SOURCE Azenta
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.